Yield10 enters warrant exercise agreements, reduces price to $0.43 and issues new warrants

YIELD10 BIOSCIENCE, INC.

Existing holders to exercise 3,191,140 warrants (issued May and Aug 2023) at reduced price of $0.43/share, generating cash proceeds.
Company issues new unregistered warrants to purchase 6,382,280 shares (200% of exercised shares) at $0.43/share, five-year term.
Shareholder meeting required within 90 days to approve issuance of new warrants and underlying shares under Nasdaq rules.
New warrants include cashless exercise option and beneficial ownership limitation of 9.99% (max 19.99% with 61-day notice).
Maxim Group to receive 7.0% cash fee on gross proceeds from exercised warrants as solicitation agent.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

YIELD10 BIOSCIENCE, INC. entered into warrant exercise agreements with certain existing institutional investors (effective 2024-03-22).

Action: entry
Counterparty: certain existing institutional investors
Effective: 2024-03-22

Exact text from the filing

On March 22, 2024, Yield10 Bioscience, Inc., a Delaware corporation (the “ Company ”), entered into warrant exercise agreements (the “ Agreements ”) with certain existing institutional investors

View on SEC.gov

547 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001104659-24-037856

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.